Dossiers › 2023/0131(COD)
Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
Ordinary legislative procedure · Second reading · Committee responsible: Environment, Climate and Food Safety, Public Health · Opinion: Budgetary Control, Agriculture and Rural Development, Internal Market and Consumer Protection, Budgets, Civil Liberties, Justice and Home Affairs
Details
Plenary votes
No roll-call vote on this dossier yet.
Source: European Parliament roll-call votes, via HowTheyVote (ODbL). Collected 8 November 2026.
Timeline
- Committee tabling report12 October 2026
- Referred to committee8 October 2026
- Committee approved the provisional agreement18 March 2026
- Negotiation with Council and Commission10 December 2025
- Negotiation with Council and Commission11 November 2025
- Negotiation with Council and Commission7 October 2025
- Negotiation with Council and Commission17 June 2025
- Plenary amend proposal10 April 2024
- Plenary debate10 April 2024
- Plenary vote10 April 2024
Source: European Parliament Legislative Observatory and Open Data API (CC BY 4.0).
Rapporteurs
- Tiemo WölkenRapporteurS&D · DE
- Tiemo WölkenRapporteurS&D · DE
- Henna VirkkunenShadow rapporteur ·
- Johan Van OvertveldtShadow rapporteurECR · BE
- Norbert LinsShadow rapporteurEPP · DE
- Anders VistisenShadow rapporteur ·
- Andrey SlabakovShadow rapporteur ·
- Christine AndersonShadow rapporteurESN · DE
- Frédérique RiesShadow rapporteur ·
- Giorgos GeorgiouShadow rapporteurThe Left · CY
- Kateřina KonečnáShadow rapporteurPfE · CZ
- Margarita De La Pisa CarriónShadow rapporteurPfE · ES
Follow this dossier
Get an e-mail when it moves: committee vote, negotiation or plenary.